CO-DIAGNOSTICS, INC. (CODX) Financial Statements
CO-DIAGNOSTICS, INC. (CODX) files with the U.S. Securities and Exchange Commission under CIK 0001692415. 10KGenie shows its annual and quarterly statements from SEC filings.
Key Figures, Fiscal Year 2025
- Revenue
- $622.49 thousand
- Net Income
- -$46.90 million
- Total Assets
- $24.74 million
- Net Cash from Operations
- -$29.14 million
Fiscal year ended Dec 31, 2025. Latest periodic SEC filing: Aug 13, 2026. Source: SEC filings (EDGAR XBRL).
Open the full financial statements for CODX in 10KGenie
Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History